Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium 
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
-- Conference Call to Follow at 4:30 p.m. EDT --
HORSHAM, Pa., Feb. 21, 2018 -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, will release fourth quarter and fiscal 2017 financial results on Thursday, March 8, after the market close. STRATA Skin Sciences’ President and Chief Executive Officer, Frank J. McCaney, will host a conference call at 4:30 pm Eastern Time to review the Company’s progress and answer questions.
| Conference Call Details: | ||
| Date: | Thursday, March 8 | |
| Time: | 4:30 pm Eastern Time | |
| Toll Free: | 888-394-8218 | |
| International: | 323-794-2149 | |
| Passcode: | 6380302 | |
| Webcast: | www.strataskinsciences.com |
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company focused on the therapeutic and aesthetic dermatology market. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN® MicroSystem, marketed specifically for the intended use of micropigmentation; and NORDLYS, a multi-technology aesthetic laser device.
| Investor Contacts: | ||
| Frank McCaney, Chief Executive Officer | Bob Yedid, Managing Director | |
| STRATA Skin Sciences, Inc. | LifeSci Advisors, LLC | |
| 215-619-3200 | 646-597-6989 | |
| [email protected] | [email protected] |
